This content is machine translated Antiplatelet agents Ticagrelor reduces risk of recurrent stroke After an acute cerebral infarction or a transient ischemic attack (TIA), the risk of another stroke is massively increased. That early treatment with an antiplatelet agent contributes to secondary prevention…
View Post 2 min This content is machine translated Acute coronary syndrome What medications can be used in everyday practice? In the first-line treatment of acute coronary syndrome (ACS), ticagrelor and prasugrel have been shown to be effective, according to PD Jan Steffel, MD, Zurich.
